Correlation Between NextCure and Anavex Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NextCure and Anavex Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and Anavex Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and Anavex Life Sciences, you can compare the effects of market volatilities on NextCure and Anavex Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of Anavex Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and Anavex Life.

Diversification Opportunities for NextCure and Anavex Life

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between NextCure and Anavex is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and Anavex Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anavex Life Sciences and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with Anavex Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anavex Life Sciences has no effect on the direction of NextCure i.e., NextCure and Anavex Life go up and down completely randomly.

Pair Corralation between NextCure and Anavex Life

Given the investment horizon of 90 days NextCure is expected to under-perform the Anavex Life. But the stock apears to be less risky and, when comparing its historical volatility, NextCure is 2.03 times less risky than Anavex Life. The stock trades about -0.37 of its potential returns per unit of risk. The Anavex Life Sciences is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  803.00  in Anavex Life Sciences on September 15, 2024 and sell it today you would earn a total of  27.00  from holding Anavex Life Sciences or generate 3.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NextCure  vs.  Anavex Life Sciences

 Performance 
       Timeline  
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Anavex Life Sciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Anavex Life Sciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Anavex Life disclosed solid returns over the last few months and may actually be approaching a breakup point.

NextCure and Anavex Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NextCure and Anavex Life

The main advantage of trading using opposite NextCure and Anavex Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, Anavex Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anavex Life will offset losses from the drop in Anavex Life's long position.
The idea behind NextCure and Anavex Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins